Literature DB >> 27923247

Patterns of Empiric Antibiotic Administration for Presumed Early-Onset Neonatal Sepsis in Neonatal Intensive Care Units in the United States.

Emily A Oliver1, Patricia B Reagan1, Jonathan L Slaughter1, Catalin S Buhimschi1, Irina A Buhimschi1.   

Abstract

Objective To evaluate current patterns in empiric antibiotic use for early-onset neonatal sepsis (EONS). Study Design Retrospective population-based cohort study of newborns admitted on postnatal day 0 to 1 and discharged from NICUs participating in the Pediatric Health Information System (PHIS 2006-2013). Analyses included frequency of antibiotic initiation within 3 days of birth, duration of first course, and variation among hospitals. Results Of 158,907 newborns, 118,624 (74.7%) received antibiotics on or before postnatal day 3. Within 3 days of treatment, 49.4% (n = 58,610) were discharged home or remained hospitalized without antibiotics. There was marked interhospital variation in the proportion of infants receiving antibiotics (range: 52.3-90.9%, mean 77.9%, SD 11.0%) and in treatment days (range: 3.2-8.6, mean 5.3, SD 1.4). Facilities with higher number of newborns started on antibiotics had longer courses (r = 0.643, p < 0.001). The cost of admissions for infants born at ≥35 weeks started on antibiotics and discharged home after no more than 3 days of antibiotics was $76,692,713. Conclusion Site variation in antibiotic utilization suggests antibiotic overtreatment of infants with culture unconfirmed EONS is common and costly. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27923247     DOI: 10.1055/s-0036-1596055

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  10 in total

1.  Antibiotic stewardship in NICU: De-implementing routine CRP to reduce antibiotic usage in neonates at risk for early-onset sepsis.

Authors:  Neetu Singh; James E Gray
Journal:  J Perinatol       Date:  2021-06-08       Impact factor: 2.521

2.  Antibiotic exposure prevents acquisition of beneficial metabolic functions in the preterm infant gut microbiome.

Authors:  Yanping Xu; Olivia Milburn; Traci Beiersdorfer; Lizhong Du; Henry Akinbi; David B Haslam
Journal:  Microbiome       Date:  2022-07-07       Impact factor: 16.837

3.  Improving Antibiotic Stewardship among Asymptomatic Newborns Using the Early-onset Sepsis Risk Calculator.

Authors:  Marty Ellington; Kavita Kasat; Kim Williams; Victoria Reichman; Guillaume Stoffels; Tung Ming Leung; Ana Degoy; Rebecca Fisk; Luisa Gonzalez-Ballesteros; Dinabel Peralta-Reich; Aaron Potash; Kavya Rao
Journal:  Pediatr Qual Saf       Date:  2021-08-26

4.  The NICU Antibiotics and Outcomes (NANO) trial: a randomized multicenter clinical trial assessing empiric antibiotics and clinical outcomes in newborn preterm infants.

Authors:  Michael J Morowitz; Anup C Katheria; Richard A Polin; Elizabeth Pace; David T Huang; Chung-Chou H Chang; Johathan G Yabes
Journal:  Trials       Date:  2022-05-23       Impact factor: 2.728

Review 5.  Early-Life Host-Microbiome Interphase: The Key Frontier for Immune Development.

Authors:  Nelly Amenyogbe; Tobias R Kollmann; Rym Ben-Othman
Journal:  Front Pediatr       Date:  2017-05-24       Impact factor: 3.418

Review 6.  Rational Use of Medicines in Neonates: Current Observations, Areas for Research and Perspectives.

Authors:  Karel Allegaert
Journal:  Healthcare (Basel)       Date:  2018-09-14

7.  Antibiotic Treatment of Suspected and Confirmed Neonatal Sepsis Within 28 Days of Birth: A Retrospective Analysis.

Authors:  Jadon S Wagstaff; Robert J Durrant; Michael G Newman; Rachael Eason; Robert M Ward; Catherine M T Sherwin; Elena Y Enioutina
Journal:  Front Pharmacol       Date:  2019-10-15       Impact factor: 5.810

8.  Umbilical cord miRNAs to predict neonatal early onset sepsis.

Authors:  Linda M Ernst; Leena B Mithal; Karen Mestan; Vivien Wang; Kathy A Mangold; Alexa Freedman; Sanchita Das
Journal:  PLoS One       Date:  2021-05-07       Impact factor: 3.240

9.  Managing antibiotics wisely in a neonatal intensive care unit in a low resource setting.

Authors:  Juan M Graus; Cecilia Herbozo; Roger Hernandez; Alfonso Francisco Pantoja; Jaime Zegarra
Journal:  J Perinatol       Date:  2022-04-22       Impact factor: 3.225

10.  Optimal dose of cefotaxime in neonates with early-onset sepsis: A developmental pharmacokinetic model-based evaluation.

Authors:  Zhen-Hai Shang; Yue-E Wu; Dong-Mei Lv; Wei Zhang; Wen-Qiang Liu; John van den Anker; Yan Xu; Wei Zhao
Journal:  Front Pharmacol       Date:  2022-09-07       Impact factor: 5.988

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.